Evidence map›Paper›PMID 31145282›Full record

ArticleMedicine2019

Risk of multiple early gastric cancers in a patient with precursor lesions and endoscopic surveillance for 7 years: A case report.

Hui Pan, Chaoying Fang, Liping He, Houqiang Li, Lanzai Liu, Chao Wang, Jiansu Chen

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hui PanGastrointestinal Endoscopy Center, Fujian Provincial Hospital South Branch.
Chaoying FangGastrointestinal Endoscopy Center, Fujian Provincial Hospital South Branch.
Liping HeGastrointestinal Endoscopy Center, Fujian Provincial Hospital.
Houqiang LiDepartment of Pathology, Fujian Provincial Hospital South Branch, Fuzhou, China.
Lanzai LiuGastrointestinal Endoscopy Center, Fujian Provincial Hospital South Branch.
Chao WangGastrointestinal Endoscopy Center, Fujian Provincial Hospital South Branch.
Jiansu ChenGastrointestinal Endoscopy Center, Fujian Provincial Hospital South Branch.
Fujian Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleSevere mucosal atrophy or intestinal metaplasia is a risk factor for synchronous and metachronous intestinal gastric cancer. Magnifying endoscopy with narrow-band imaging was useful for assessing differentiated early gastric cancer (EGC). PATIENT CONCERNS: A 62-year-old Chinese female was diagnosed with 5 multiple EGCs or high-grade dysplasia (HGD) with endoscopic surveillance for 7 years. DIAGNOSES: Synchronous and metachronous multiple EGCs.

interventionsEndoscopic submucosal dissection (ESD) with en bloc resection was performed for all 5 multiple lesions. The ESD specimens were pathologically diagnosed with adenocarcinoma confined to the mucosa or HGD. OUTCOMES: After endoscopy resection, no residual, recurrent, or synchronous lesions were detected by endoscopic surveillance after ESD. LESSONS: Long-term, meticulous endoscopic surveillance is needed to monitor risk factors associated with multiple EGCs in patients with severe mucosal atrophy or intestinal metaplasia despite successful Helicobacter pylori eradication.

Indexed as

AdenocarcinomaEndoscopic Mucosal ResectionFemaleGastric MucosaGastroscopyHumansMetaplasiaMiddle AgedNarrow Band ImagingPrecancerous ConditionsRisk FactorsStomach NeoplasmsTime FactorsWatchful Waiting

Identifiers

PMID31145282
PMCPMC6708962
OpenAlexW2947656206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.